University of Gothenburg
University of Gothenburg
  2. About
  3. Find staff
  4. Mikael Alsterholm

Mikael Alsterholm

Affiliated to Research

Department of Dermatology and
Venereology
Telephone
+46 31-342 97 84
Mail
mikael.alsterholm@gu.se
Visiting address
Gröna stråket 16 Pl 2 SU/Sahlgrensk
41345 Göteborg
Postal address
Sahlgrenska Universitetssjukhuset
41345 Göteborg

About Mikael Alsterholm

Mikael Alsterholm is a senior consultant in dermatology and venereology and a postdoctoral researcher with a PhD in Medical Science. He has been section manager at the clinical department of dermatology and venereology at Sahlgrenska University Hospital during 2011-2023.

He is a member of the steering group for SwedAD – the Swedish nation-wide quality registry for atopic dermatitis.

Research focus area

Mikael Alsterholm's research focuses on different aspects of treatment and follow-up of atopic dermatitis (eczema).

Atopic dermatitis affects 20% of children and 10% of adults living in Sweden and the prevalence is similar in other parts of the world. Individuals with atopic dermatitis suffer greatly from itch, sleep disturbance, and skin lesions that affect social interaction and quality of life. In recent years new systemic pharmacotherapies for atopic dermatitis have been introduced. These new treatments can be very effective but real-world data is still limited. To improve health-related quality of life for the large group of patients with atopic dermatitis it is important to investigate the effect and safety of new and conventional therapies, predictors of efficacy, and patients´ perception and experience of these therapies.

Mikael Alsterholm's current work includes registry-based studies of the outcome of systemic treatment for atopic dermatitis, clinical interventional studies on the effect of phototherapy on vitamin D metabolism in atopic dermatitis, and a digital questionnaire study on patients’ experiences of side effects of treatment with topical corticosteroids. The work is done in collaboration with researchers at Karolinska Institutet, Linköping University, Umeå University and in the steering group for SwedAD.